Matthew DiCanio; President and Chief Financial Officer; Concentra Group Holdings Parent Inc ...
BofA raised the firm’s price target on Concentra (CON) to $25 from $24 and keeps a Buy rating on the shares after the company announced an ...
Three weeks after Redx Pharma and Jounce Therapeutics announced a merger, their plans have been disrupted by an unsolicited offer for Jounce from little-known Concentra Biosciences. Little is ...
ADDISON, Texas--(BUSINESS WIRE)--Concentra Group Holdings Parent, Inc. (“Concentra,” “we,” “us,” or “our”) (NYSE: CON) today announced that Select ...
Concentra reports a robust quarter with significant EBITDA growth and a promising outlook following the Nova Medical Centers acquisition.